Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial.
Journal: JAMA dermatology
Published: August 26, 2026
Targeting the Metabolic-Inflammatory Axis in Psoriasis and Psoriatic Arthritis: Evidence From Diet, Glucagon-like Peptide-1 Receptor Agonists, and Patient Perspectives.
Journal: The Journal of rheumatology
Published: July 07, 2026
Artificial intelligence versus experts: Navigating challenging cases in psoriatic disease.
Journal: The Journal of investigative dermatology
Published: May 05, 2026
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
Journal: The New England journal of medicine
Published: March 30, 2026
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
Journal: The New England journal of medicine
Published: March 30, 2026
Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials.
Journal: Nature reviews. Rheumatology
Published: December 19, 2025
Key Strategies for Sustaining an Interprofessional Continuing Education Program.
Journal: Journal of CME
Published: November 12, 2025
Cutaneous Epithelioid/Pleomorphic Rhabdomyosarcoma, Melanoma in Disguise? An Immunohistochemical, Molecular, and Epigenetic Study of 13 Patients.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 02, 2025
Assessment of Cutaneous and Mucosal Direct Immunofluorescence Testing Practices in the US.
Journal: JAMA dermatology
Published: April 02, 2025
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project.
Journal: Rheumatology (Oxford, England)
Published: March 04, 2025
Last Updated: 09/26/2026